arrow
D

David J. Ponting

lhasa limited
H指数:19
被引数:1,079

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Applicability of the ICH M7 Guidelines for Assessing Less-than-Lifetime Exposure to Nitrosamine Impurities in Drug Products

ICH M7指导原则在评估药物产品中亚硝胺杂质低于一生暴露情况下的适用性

2026-09-110
OAAI
Ames Concordance with the In Vivo Transgenic Rodent (TGR) Gene Mutation Assay for NDSRIs and Relative In Vivo TGR Potency with Nitrosamines with Robust Dose-Response Carcinogenicity Data
2026-01-300
PRE
Evaluating the Lifetime Cumulative Dose as a Basis for Carcinogenic Potency of Nitrosamines – a Key Tenet Underpinning Less-than-Lifetime Approaches for Establishing Acceptable Intake limits

评估亚硝胺致癌强度的终身累积剂量——这是支持采用非终身方法制定可接受摄入限值的关键原则。

2025-07-090
OAAI
Control of N-nitrosamine impurities in drug products: Progressing the current CPCA framework and supporting the derivation of robust compound specific acceptable intakes

药物产品中N-亚硝胺杂质的控制: 推进当前CPCA框架并支持稳健化合物特定可接受摄入量的推导

2025-02-010
PRE